724 related articles for article (PubMed ID: 8612408)
1. Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations.
Van den Berghe G; de Zegher F; Vlasselaers D; Schetz M; Verwaest C; Ferdinande P; Lauwers P
Crit Care Med; 1996 Apr; 24(4):590-5. PubMed ID: 8612408
[TBL] [Abstract][Full Text] [Related]
2. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
[TBL] [Abstract][Full Text] [Related]
3. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
Sarne DH; Sobieszczyk S; Ain KB; Refetoff S
J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
[TBL] [Abstract][Full Text] [Related]
4. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
[TBL] [Abstract][Full Text] [Related]
5. Dopamine suppresses pituitary function in infants and children.
Van den Berghe G; de Zegher F; Lauwers P
Crit Care Med; 1994 Nov; 22(11):1747-53. PubMed ID: 7956277
[TBL] [Abstract][Full Text] [Related]
6. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
Snyder PJ; Utiger RD
J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
[TBL] [Abstract][Full Text] [Related]
7. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
Kaplan MM; Taft JA; Reichlin S; Munsat TL
J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628
[TBL] [Abstract][Full Text] [Related]
8. [The hypothalamic-Pituitary thyroid axis: studies on the regulatory role of thyrotropin releasing hormone (TRH) (author's transl)].
Hirooka Y
Nihon Naibunpi Gakkai Zasshi; 1976 Sep; 52(9):908-25. PubMed ID: 828584
[TBL] [Abstract][Full Text] [Related]
9. Alterations in basal and TRH-stimulated serum levels of thyrotropin, prolactin, and thyroid hormones in starved obese men.
Carlson HE; Drenick EJ; Chopra IJ; Hershman JM
J Clin Endocrinol Metab; 1977 Oct; 45(4):707-13. PubMed ID: 410822
[TBL] [Abstract][Full Text] [Related]
10. The influence of long-term low dose thyrotropin-releasing hormone infusions on serum thyrotropin and prolactin concentrations in man.
Spencer CA; Greenstadt MA; Wheeler WS; Kletzky OA; Nicoloff JT
J Clin Endocrinol Metab; 1980 Oct; 51(4):771-5. PubMed ID: 6774994
[TBL] [Abstract][Full Text] [Related]
11. Effects of tartrate thyrotropin-releasing hormone treatment on serum thyrotropin, free triiodothyronine, free thyroxine and prolactin levels in patients with spinocerebellar degeneration.
Merola B; Colao A; Di Renzo G; Filla A; Campanella G; Lombardi G
Horm Res; 1992; 38(3-4):160-3. PubMed ID: 1306848
[TBL] [Abstract][Full Text] [Related]
12. Effects of obesity, total fasting and re-alimentation on L-thyroxine (T4), 3,5,3'-L-triiodothyronine (T3), 3,3',5'-L-triiodothyronine (rT3), thyroxine binding globulin (TBG), cortisol, thyrotrophin, cortisol binding globulin (CBG), transferrin, alpha 2-haptoglobin and complement C'3 in serum.
Scriba PC; Bauer M; Emmert D; Fateh-Moghadam A; Hofmann GG; Horn K; Pickardt CR
Acta Endocrinol (Copenh); 1979 Aug; 91(4):629-43. PubMed ID: 115194
[TBL] [Abstract][Full Text] [Related]
13. Triiodothyronine administration reduces serum growth hormone levels and growth hormone responses to thyrotropin-releasing hormone in patients with anorexia nervosa.
Valcavi R; Zini M; Portioli I
Psychoneuroendocrinology; 1990; 15(4):287-95. PubMed ID: 2128417
[TBL] [Abstract][Full Text] [Related]
14. Preferential release of tri-iodothyronine following stimulation by thyrotrophin or thyrotrophin-releasing hormone in sheep of different ages.
Peeters R; Buys N; Vanmontfort D; Van Isterdael J; Decuypere E; Kühn ER
J Endocrinol; 1992 Jan; 132(1):93-100. PubMed ID: 1737964
[TBL] [Abstract][Full Text] [Related]
15. Effect of endotoxin on hormonal responses to thyrotropin and thyrotropin-releasing hormone in dogs.
Yu AA; Kemppainen RJ; MacDonald JM
Am J Vet Res; 1998 Feb; 59(2):186-91. PubMed ID: 9492934
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues.
Van den Berghe G; de Zegher F; Baxter RC; Veldhuis JD; Wouters P; Schetz M; Verwaest C; Van der Vorst E; Lauwers P; Bouillon R; Bowers CY
J Clin Endocrinol Metab; 1998 Feb; 83(2):309-19. PubMed ID: 9467533
[TBL] [Abstract][Full Text] [Related]
17. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
Andreassen B; Huth J; Tyson JE
Am J Obstet Gynecol; 1979 Nov; 135(6):737-42. PubMed ID: 115316
[TBL] [Abstract][Full Text] [Related]
18. Effect of prolonged oral administration of TRH on plasma levels of thyrotrophin and prolactin in normal individuals and in patients with primary hypothyroidism.
Frey HM; Haug E
Acta Endocrinol (Copenh); 1977 Aug; 85(4):744-52. PubMed ID: 407759
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of thyroxine, 3,5,3'-triiodothyronine, thyrotropin, and prolactin in dogs before and after thyrotropin-releasing hormone administration.
Kaufman J; Olson PN; Reimers TJ; Allen TA; Soderberg SF; Nett TM; Wheeler SL; Wingfield WE
Am J Vet Res; 1985 Feb; 46(2):486-92. PubMed ID: 3922262
[TBL] [Abstract][Full Text] [Related]
20. Thyrotropin and prolactin secretory patterns during 24-hours infusion of thyrotropin-releasing hormone in calves.
Ohlson DL; Davis SL; Anfinson MS; Klindt J
Neuroendocrinology; 1978; 26(3):163-73. PubMed ID: 98724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
